The goal of the K23 candidate is to establish a high-quality independent research program on neuroimaging, particularly on improving network analytical techniques of molecular imaging and to study neurodegenerative disorders. Dementias, including Alzheimer's disease (AD), are network degenerative disorders. For instance, it is well known that AD pathology spreads along distributed brain systems within neuronal networks. However, at present there is no direct in vivo method to visualize large-scale network degeneration and propagation in individuals suffering from dementia. Hence there is a critical need for developing novel and comprehensive analytical methods that accurately detect brain pathological networks (BPNs). In this proposal, we aim to develop graph theoretical tools to visualize and study BPNs in preclinical - that is, normal older individuals at risk for AD by virtue of advanced age- and clinical AD subjects using positron emission tomography (PET). Particularly, we will construct group-level brain graphs using multi- regression models and PET images from two key AD pathological radioligands: 1) 11C-labeled Pittsburgh Compound-B (11C-PIB) that binds fibrillar amyloid-beta (A?) plaques; and 2) F18-T807 that binds TAU neurofibrillary tangles (Aim 1). Then, we will develop graph theory metrics to estimate network propagation patterns in group-level A? and TAU BPNs (Aim 2). Finally, we will investigate individual mapping of BPNs and its relationship with individual risk for AD, functional connectivity breakdown, and neuropsychological profiles (Aim 3). We believe this research can dramatically improve our detection and visualization capabilities of in vivo network degeneration in AD and dementia. Neuroimaging methods designed to characterize BPNs -as a proxy of network degeneration- promise to improve diagnosis and monitoring of therapeutic response in dementia, which might in turn positively impact the U.S. health care system burdened by these devastating disorders. Moreover, completion of the proposed award will provide the foundation for the candidate's development as an independent investigator, complementing the candidate's prior skills with rigorous training in molecular PET imaging. The candidate will take advantage of the cutting-edge facilities, as well as the world- class educational opportunities at its collaborating institutions. During the K23 award, the candidate will have the valuable support and mentorship of Prof. Keith A. Johnson and Prof. Thomas Brady. Relevance: This proposal has the potential to improve public health through advancement of the PET capabilities to early diagnose and monitor dementia.

Public Health Relevance

Currently, there is no direct method to map in vivo network degeneration in individuals suffering from pre-clinical or clinical dementia. In this project, we propose to develop novel and comprehensive imaging methods to accurately detect pathological neurodegeneration at the brain network level. We believe this research can dramatically improve diagnosis and monitoring of therapeutic response in preclinical and clinical dementia, which might in turn positively impact the U.S. health care system burdened by these devastating disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
5K23EB019023-02
Application #
8898795
Study Section
Special Emphasis Panel (ZEB1-OSR-F (M2))
Program Officer
Erim, Zeynep
Project Start
2014-08-01
Project End
2019-07-31
Budget Start
2015-08-01
Budget End
2016-07-31
Support Year
2
Fiscal Year
2015
Total Cost
$154,423
Indirect Cost
$11,439
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02114
Qian, Jingyu; Diez, Ibai; Ortiz-Terán, Laura et al. (2018) Positive Connectivity Predicts the Dynamic Intrinsic Topology of the Human Brain Network. Front Syst Neurosci 12:38
Buckley, Rachel F; Mormino, Elizabeth C; Amariglio, Rebecca E et al. (2018) Sex, amyloid, and APOE ?4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts. Alzheimers Dement 14:1193-1203
Jacobs, Heidi I L; Hedden, Trey; Schultz, Aaron P et al. (2018) Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals. Nat Neurosci 21:424-431
Ruiz de Miras, Juan; Costumero, Víctor; Belloch, Vicente et al. (2017) Complexity analysis of cortical surface detects changes in future Alzheimer's disease converters. Hum Brain Mapp 38:5905-5918
Pr?kovska, Vesna; Huijbers, Willem; Schultz, Aaron et al. (2017) Epicenters of dynamic connectivity in the adaptation of the ventral visual system. Hum Brain Mapp 38:1965-1976
Schultz, Aaron P; Chhatwal, Jasmeer P; Hedden, Trey et al. (2017) Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals. J Neurosci 37:4323-4331
LaPoint, Molly R; Chhatwal, Jasmeer P; Sepulcre, Jorge et al. (2017) The association between tau PET and retrospective cortical thinning in clinically normal elderly. Neuroimage 157:612-622
Ortiz-Terán, Laura; Diez, Ibai; Ortiz, Tomás et al. (2017) Brain circuit-gene expression relationships and neuroplasticity of multisensory cortices in blind children. Proc Natl Acad Sci U S A 114:6830-6835
Sepulcre, Jorge; Sabuncu, Mert R; Li, Quanzheng et al. (2017) Tau and amyloid ? proteins distinctively associate to functional network changes in the aging brain. Alzheimers Dement 13:1261-1269
Sepulcre, Jorge; Schultz, Aaron P; Sabuncu, Mert et al. (2016) In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain. J Neurosci 36:7364-74

Showing the most recent 10 out of 13 publications